26 Apr 2019
The 24th Annual General Meeting of Merck KGaA, Darmstadt, Germany, will take place on April 26, 2019 at the Jahrhunderthalle in Frankfurt am Main, Germany
We discover and develop for life in all its vibrancy, from great human questions to small everyday joys. For more than 350 years, curiosity has been driving us to deliver excellence to patients and our customers – and to imagine the future.
We think in generations, not only in quarters. Our approach to corporate responsibility is simple: We look, listen and do things better.Responsibility at our company
We are a science and technology company driven by a passion for research and discovery. It is a special honor for me to lead this unique company. We are well-positioned for sustainable and profitable growth. We have a lot planned. We are curious about the future. I hope that you share our curiosity.
Chairman of the Executive Board and CEO of
Merck KGaA, Darmstadt, Germany
The Merck Foundation is the Philanthropic arm of Merck. It is a non-profit organization that aims to improve the health and wellbeing of people and advance their lives through science and technology.Discover more
Many of our achievements in science and technology are built on strong partnerships. We join forces with companies, researchers and bold innovators from all over the world.Learn More
Merck KGaA, Darmstadt, Germany, today commenced a cash Tender Offer to acquire all outstanding shares of Versum Materials, Inc. (NYSE: VSM) for $48 per share, without interest and less any withholding taxes.
Merck KGaA, Darmstadt, Germany today announced that MAVENCLAD® (cladribine tablets) has been approved for the treatment of highly active relapsing remitting multiple sclerosis (RRMS) in Switzerland.
Merck KGaA, Darmstadt, Germany today officially announced the opening of a new M Lab™ Collaboration Center in Molsheim, France. The center is the first in Europe and ninth worldwide for the company’s...